Gupta P, Godfrey EL, Schultz KS, Qiao L, Aguirre N, Bader JM, Foote MB, Shen JP, Shergill AP, Cecchini M, Sundar R, Sheltzer JM, Turaga KK. Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases. Ann Surg Oncol 2026 PMID: 41634518, DOI: 10.1245/s10434-025-19057-z.
Peer-Reviewed Original Research
This study investigates drug sensitivity in colorectal cancer peritoneal metastases, showing CMS4 tumors respond better to mitomycin-C and irinotecan, informing personalized chemotherapy strategies.